Status:
COMPLETED
Risk Reduction in Coronary Heart Disease
Lead Sponsor:
Sorlandet Hospital HF
Collaborating Sponsors:
Oslo University Hospital
Conditions:
Coronary Heart Disease
Eligibility:
All Genders
18-79 years
Phase:
NA
Brief Summary
Study hypothesis: Multifactorial risk reduction in coronary heart disease can reduce the risk of new coronary heart disease and death
Eligibility Criteria
Inclusion
- acute myocardial infarction, CABG or PCI
Exclusion
- Age \< 18 and age \> 80
- pregnant
- critical illness
- drug abuse
Key Trial Info
Start Date :
September 1 2007
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 1 2019
Estimated Enrollment :
1600 Patients enrolled
Trial Details
Trial ID
NCT00679237
Start Date
September 1 2007
End Date
December 1 2019
Last Update
March 17 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Sorlandet Hospital
Arendal, Norway